Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 1 |
2024 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
IL12/23 Blockade with Ustekinumab as a Treatment for Immune-Related Cutaneous Adverse Events.
Pharmaceuticals (Basel). 2023 Nov 2;16(11):1548. doi: 10.3390/ph16111548.
Pharmaceuticals (Basel). 2023.
PMID: 38004414
Free PMC article.
Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways.
Lacouture ME, Goleva E, Shah N, Rotemberg V, Kraehenbuehl L, Ketosugbo KF, Merghoub T, Maier T, Bang A, Gu S, Salvador T, Moy AP, Lyubchenko T, Xiao O, Hall CF, Berdyshev E, Crooks J, Weight R, Kern JA, Leung DYM.
Lacouture ME, et al. Among authors: maier t.
Clin Cancer Res. 2024 Apr 23. doi: 10.1158/1078-0432.CCR-23-3431. Online ahead of print.
Clin Cancer Res. 2024.
PMID: 38652814
Item in Clipboard
Cite
Cite